
    
      The investigators are testing the following hypothesis:

      In a population of patients who present to an ED with acute migraine and have been treated
      with parenteral metoclopramide unsuccessfully, bilateral greater occipital nerve blocks with
      bupivicaine will provide greater rates of short-term and sustained headache freedom than
      bupivacaine injected intradermally.
    
  